[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $inmb

Inmune Bio's Phase X Alzheimer's results for Pegipanermin are set for presentation on December 1st, amidst discussions of potential short and gamma squeezes.

### About $inmb
Inmune Bio is a biotechnology company focused on developing therapies for cancer and neurodegenerative diseases.  

### Insights
- $inmb sentiment is up XXXXXX% from the previous X months.

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$inmb/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$inmb/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXXX  
X Week: XXXXXX -XX%  
X Month: XXXXXXX +25%  
X Months: XXXXXXXXXX +2,195%  
X Year: XXXXXXXXXX +4,509%  
1-Year High: XXXXXXXXX on 2025-09-16  
1-Year Low: XX on 2024-12-25  

Engagements by network (24h):
X: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$inmb/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$inmb/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XXX  
X Week: XX -XX%  
X Month: XXX +43%  
X Months: XXXXXX +12,687%  
X Year: XXXXXX +12,294%  
1-Year High: XXXXXX on 2025-07-04  
1-Year Low: X on 2024-12-25  

Mentions by network (24h):
X: XX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$inmb/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$inmb/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $inmb in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: XXX  
X Week: XX -XX%  
X Month: XXX +20%  
X Months: XXXXXX +15,585%  
X Year: XXXXXX +15,631%  
1-Year High: XXXXX on 2025-07-04  
1-Year Low: X on 2025-12-07  

The most influential creators that mention $inmb in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X    | XXXXXX    | X     | XXX         |

[View More](/list/creators/$inmb/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$inmb/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$inmb/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% +50%  
X Month: XXX% +60%  
X Months: XXX% no change  
X Year: XXX% no change  
1-Year High: XXX% on 2024-12-12  
1-Year Low: X% on 2025-09-16  

Most Supportive Themes:
- Alzheimer's Disease Results Presentation: (10%) Inmune Bio will present Phase X Alzheimer's disease results for Pegipanermin on December 1st.
- Intellectual Property Strategy: (5%) Josh Schoonover, Inmune Bio's in-house counsel, leads the company's IP strategy and has driven significant patent acquisitions.
  
Most Critical Themes:
- Short and Gamma Squeeze Mentions: (30%) Multiple posts mention $INMB in the context of potential short and gamma squeezes, alongside numerous other tickers.
- Options Trading Mentions: (25%) $INMB is mentioned in the context of options trading, including put options, with varying sentiment.
- Stock Performance Comparisons: (20%) $INMB is mentioned alongside other stocks in discussions about performance, including predictions of significant drops.
  

### Top $inmb Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"🤰🤿 For those asking how I find my trading ideas: I follow Prof. @LarThone's free daily alerts. His analysis as a finance professor is next level. #SP500 #NXXTFedBoost $BULL #ShortSelling🐄 $INTT #BlackSwanEvent👮 $IMA #ElectricVehicles🎍 $ITOS #MergersandAcquisitions👠 $INMB"  
[X Link](https://x.com/MDearco57177/status/1998985879575240919) [@MDearco57177](/creator/x/MDearco57177) 2025-12-11T05:19Z X followers, XX engagements


"$INMB low vol but - INmune Bio Terminates $75M At-the-Market Sales Agreement With RBC Capital Markets And $BTIG Effective December XX 2025; Prior To Termination The Co Issued And Sold 1353469 Shares Of Common Stock Under The Sales Agreement Raising Net Proceeds Of$10.5M"  
[X Link](https://x.com/thestockblog/status/1998969407448731969) [@thestockblog](/creator/x/thestockblog) 2025-12-11T04:13Z 6074 followers, XXX engagements


"Top breakouts since yesterday $INMB $WRBY $TRIB at 9:06am pst"  
[X Link](https://x.com/BreakoutStocks/status/1998439087225843888) [@BreakoutStocks](/creator/x/BreakoutStocks) 2025-12-09T17:06Z 115.4K followers, XXX engagements


"🧬 Biopharma Weekly Recap 📝 This week in biotech: China dealmaking surges obesity programs and competitive dynamics intensify FDA shifts spotlight reviews and rare disease and cell therapy updates drive focus. See interesting posts/ppl to check out 👇 @Biotech2k1 Biotech Forever X names cited with high sales estimates ($INSM $BBIO $AXSM $CRNX $CYTK $PTXG $IDYA $COGT); outlook noted as subject to change. @ohadhammer Jefferies: China biotech showing record activity and R&D productivity; key issue is program differentiation. @PearlF An updated FDA org chart from @biospace @DrSamuelBHume 5"  
[X Link](https://x.com/BiopharmIQ/status/1997320319837917346) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-12-06T15:00Z 28.1K followers, 26.6K engagements